Top Device Companies

J&J’s Ethicon Endo-Surgery Sells Breast-Care Line To Devicor

Johnson & Johnson’s Ethicon Endo-Surgery has sold its breast-care business to Devicor Medical Products to become the buyer’s Mammotome subsidiary. The purchase also included Devicor marketing and distribution rights for Ethicon Endo-Surgery’s Neoprobe Gamma Detection Systems. The financial arrangements were not disclosed. Devicor is owned by a private-equity firm, GTCR Golder Rauner. (Click here for more)

“Devicor Buys Ethicon Endo-Surgery Breast Care Biz From Johnson & Johnson” – MassDevice (7/12/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

J&J Says Medical Devices 38 Percent Of Sales, Led By Depuy, Ethicon

Johnson & Johnson says its medical-device business now accounts for more than a third of the vast health-care products company’s annual sales. Medical devices and diagnostics are produced by seven companies owned by J&J, and together they account for 43 percent of profits, 38 percent of sales. The leading unit in terms of sales for the first quarter of this year was DePuy with $1.5 billion, followed by Ethicon Endo-Surgery with $1.2 billion, Ethicon at $1.12 billion, andCordis and Vision Care, each with $700 million in sales. (Click here for more)

“Johnson & Johnson Showcases Its Medical Devices” – MedCity News (6/7/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

J&J’s Ethicon Faces Re-Inspection After Inadequate Response, FDA Says

Johnson & Johnson has received another warning letter from the FDA, this one targeting problems at an Ethicon plant that makes advanced sterilization products. The letter said the ASP division of J&J’s Ethicon subsidiary failed to verify design changes and did not ensure that completed devices met necessary requirements. The division makes sterilizers and cleaning devices under the names Cidex, Evotech and Sterrad, according to the FDA. The latest warning letter said the Ethicon division has responded inadequately, so the agency planst to conduct a follow-up inspection, along with an audit and third-party certification. J&J and Ethicon did not comment. (Click here for more)

“J&J Unit Needs More Inspection After Lapses: FDA” – Reuters (5/25/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Hologic Gets $15 Million Contract To Supply Radiology Gear To Military

Hologic has been granted a $15 million contract by the U.S. Defense Department for its radiology systems and components over the next year. The contract comes in the wake of Hologic’s report of a first-quarter income loss of $26 million. The company recently settled a $12.5 million patent case with Ethicon Endo-Surgery, a unit of Johnson & Johnson. (Click here for more)

“Hologic Wins $15 Million Defense Dept. Contract” – Mass Device (4/8/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Ethicon Endo-Surgery Gets Offer To Buy Breast-Care Business

Ethicon Endo-Surgery said it is considering an offer from Devicor Medical Products to buy Ethicon’s line of biopsy equipment and rights for another product. Ethicon already was known to be considering sale of its breast-care business because it did not fit in with the firm’s future plans, an executive said. Ethicon’s breast-care products are sold in 38 countries. The rights Devicor seeks are for Ethicon’s Neoprobe Gamma Detection Systems. Ethicon has until June 10 to decide whether to accept the Devicor offer. (Click here for more)

“Ethicon Mulls Offer For Breast-Care Business” – MSN Money (3/30/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

J&J’s Ethicon Ordered To Supply Papers For Suit Against J&J’s Mentor

One Johnson & Johnson subsidiary has been ordered by a U.S. judge to produce subpoenaed documents in a case involving another J&J unit sued in a product-liability case. J&J’s Mentor is in court for its implantable ObTape device for treating stress urinary incontinence in women. The case stems from a 2005 surgery, before J&J’s acquisition of Mentor in 2008. The Mentor device is made of different material than similar devices, so the plaintiff subpoenaed Ethicon records about its competing Gynecare TVT Prolene. Ethicon, also a J&J subsidiary, tried unsuccessfully to quash the subpoena. (Click here for more)

“Judge: Ethicon Must Produce Documents In Mentor Corp. Product Liability Case” – Mass Device (1/19/10)

Hot Off the Presses: Medical Device Market 2009: Interventional Cardiology - This 86-page Special Report from IN VIVO identifies the most important trends in cardiology devices in recent years, teases out the critical decisions that drove those developments, and takes you behind the scenes and into the minds of the architects of these new technologies and business strategies. Find out more...

Covidien Files New Scalpel Patent Suit Against Ethicon Endo-Surgery

Covidien has sued Johnson & Johnson’s Ethicon Endo-Surgery unit for infringing on scalpel patents. The Covidien suit said the J&J subsidiary violated the patent when it produced the Harmonic line of ultrasonic surgical products. The suit seeks a halt to marketing the Ethicon devices and claims unspecified damages. Ethicon Endo-Surgery said it stood behind its intellectual property. The filing was enabled when a U.S. appeals court declined a suit by Covidien’s Tyco Healthcare Group, in which the court ruled ownership of the scalpel technology could not be proved. (Click here for more)

“Covidien Sues Ethicon Endo-Surgery” – Cincinnati Enquirer (Bloomberg) (1/16/10)

JUST PUBLISHED: Medical Device Market 2009: Interventional Cardiology - Find out who’s going beyond catheters and drug-eluting stents in this vibrant space with this 86-page Special Report previously published in IN VIVO: The Business & Medicine Report. Order yours now!

SpineMatrix Names Device Industry Veteran As New CEO

SpineMatrix has named William “Bill” Christy its new CEO, drawing on his 23 years in the business, most recently as CEO of AOI Medical. Naming Christy puts him at the helm of medical-device company with a product for diagnosing the source of lower back pain. Christy founded Ortheon Medical and ESD Medical and served as CEO of both, as well as CEO of Synergistic Medical Technologies. Synergistic was bought by Ethicon Endo-Surgery. (Click here for more)

“SpineMatrix Picks New CEO: Medical Device Industry Veteran William ‘Bill’ Christy” – MedCity News (12/21/09)

Hot Off the Presses: Medical Device Market 2009: Interventional Cardiology - This 86-page Special Report from IN VIVO identifies the most important trends in cardiology devices in recent years, teases out the critical decisions that drove those developments, and takes you behind the scenes and into the minds of the architects of these new technologies and business strategies. Find out more...

Ethicon Endo-Surgery Wins Appeals Battle With Covidien’s Tyco

Ethicon Endo-Surgery won a ruling from a U.S. appeals court that found the firm did not infringe on Covidien’s  Tyco Healthcare Group patents. Ethicon, a division of Johnson & Johnson, had argued at the district court level that Tyco was unable to prove its ownership of the technology involved in the dispute. Ethicon won in both courts. Covidien is a spin-off from Tyco International. (Click here for more)

“Ethicon Wins Ruling In Patent Case” – Cincinnati Enquirer (12/8/09)

Hot Off the Presses: Medical Device Market 2009: Interventional Cardiology - This 86-page Special Report from IN VIVO identifies the most important trends in cardiology devices in recent years, teases out the critical decisions that drove those developments, and takes you behind the scenes and into the minds of the architects of these new technologies and business strategies. Find out more...

Ethicon Endo-Surgery Says Studies Show Less-Invasive Ways Save

Ethicon Endo-Surgery reports favorable results from a successful pair of trials for its devices for use in minimally invasive hysterectomies, appendectomies and colectomies. The Ethicon-sponsored studies compared use of its devices using various minimally invasive procedures with normal surgery and produced results superior to open surgery. Both studies for the Johnson & Johnson subsidiary reported $4,000 in cost savings in hysterectomies and $15,000 for the other procedures. (Click here for more)

“Ethicon: Studies Show Benefits Of Less-Invasive Surgery Style” – Cincinnati Business Courier (10/26/09)

Medical Device Manufacturers’ Employee Training Programs Are Under FDA Scrutiny -- Click Here To Find Out Why...

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com